GIMERACIL for Gastric cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 27 adverse event reports in the FDA FAERS database where GIMERACIL was used for Gastric cancer.
Most Reported Side Effects for GIMERACIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 16 | 18.8% | 4 | 2 |
| Decreased appetite | 11 | 12.9% | 2 | 5 |
| Diarrhoea | 11 | 12.9% | 1 | 5 |
| Anaemia | 9 | 10.6% | 0 | 1 |
| Drug ineffective | 8 | 9.4% | 3 | 1 |
| Nausea | 8 | 9.4% | 0 | 2 |
| Vomiting | 8 | 9.4% | 0 | 0 |
| Thrombocytopenia | 7 | 8.2% | 1 | 2 |
| Myelosuppression | 6 | 7.1% | 0 | 1 |
| Neutropenia | 6 | 7.1% | 0 | 0 |
| Bone marrow failure | 5 | 5.9% | 0 | 3 |
| Fatigue | 5 | 5.9% | 1 | 1 |
| Pyrexia | 5 | 5.9% | 0 | 1 |
Other Indications for GIMERACIL
Other Drugs Used for Gastric cancer
NIVOLUMAB (3,856)
OXALIPLATIN (2,711)
CAPECITABINE (2,054)
RAMUCIRUMAB (1,257)
FLUOROURACIL (1,062)
PACLITAXEL (994)
TRASTUZUMAB (917)
CISPLATIN (802)
GIMERACIL\OTERACIL\TEGAFUR (725)
DOCETAXEL (598)